-- 
Indian Equity Movers: Cipla, Lupin, Coal India and Shriram EPC

-- B y   S h i k h a r   B a l w a n i   a n d   H e m a l   S a v a i
-- 
2011-08-24T10:56:29Z

-- http://www.bloomberg.com/news/2011-08-24/indian-equity-movers-cipla-lupin-and-coal-india.html
Shares of the following companies
had unusual moves in Indian trading. Stock symbols are in
parentheses and prices are as of the 3:30 p.m. close in Mumbai.  The Bombay Stock Exchange Sensitive Index, or Sensex, lost
213.49, or 1.3 percent, to 16,284.98. The BSE200 Index sank 1.1
percent to 2,023.70.  Drugmakers:  Lupin Ltd. (LPC)   gained 2.8 percent to
450.15 rupees while Cipla Ltd. (CIPLA IN) fell 0.4 percent to
281 rupees. Takeda Pharmaceutical Co.,  Japan ’s top drugmaker, is
in talks with Cipla and Lupin about buying their businesses in
 India , the Economic Times reported, citing people it didn’t
identify.  Coal India Ltd. (COAL)   dropped 4.7 percent to 373.9
rupees, the most since July 8. Trade bodies at the world’s
biggest producer of the fuel are demanding pay rises of as much
as 500 percent, while the actual increase is likely to be “far,
far lower” than 100 percent, R. Mohan Das, director of
personnel, said yesterday. The pollution control board of
India’s Jharkhand state has ordered a unit of the miner to close
22 open cast and underground mines in the state, PTI reported
yesterday, citing the board’s secretary S.K. Sinha.  Shriram EPC Ltd. (SEPC)   climbed 6.8 percent to 129.5
rupees, the most in more than two months. The developer of
renewable-energy projects in India said it won a 6.4 billion
rupee order to build one of the country’s first solar thermal
power plants.  To contact the reporter on this story:
Shikhar Balwani in Mumbai at 
 sbalwani@bloomberg.net ;
Hemal Savai in Mumbai at  at
 hsavai@bloomberg.net   To contact the editor responsible for this story:
Darren Boey at 
 dboey@bloomberg.net . 